|
Hu, Ying Chuan; Ahrendt, Steven A (2005) hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer. Int J Cancer 114:387-93
|
|
Casse, Celine; Hu, Ying Chuan; Ahrendt, Steven A (2003) The XRCC1 codon 399 Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer. Mutat Res 528:19-27
|
|
Ahrendt, Steven A; Hu, Yingchuan; Buta, Martin et al. (2003) p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. J Natl Cancer Inst 95:961-70
|
|
Ahrendt, Steven A; Yang, Stephen C; Wu, Li et al. (2002) Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. J Thorac Cardiovasc Surg 123:466-73; discussion 473-4
|
|
Wolf, P; Hu, Y C; Doffek, K et al. (2001) O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Cancer Res 61:8113-7
|
|
Ahrendt, S A; Decker, P A; Alawi, E A et al. (2001) Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 92:1525-30
|
|
Sanchez-Cespedes, M; Decker, P A; Doffek, K M et al. (2001) Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res 61:2092-6
|
|
Ahrendt, S A; Decker, P A; Doffek, K et al. (2000) Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer. Cancer Res 60:2488-91
|
|
Ahrendt, S A; Chow, J T; Xu, L H et al. (1999) Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 91:332-9
|
|
Ahrendt, S A; Eisenberger, C F; Yip, L et al. (1999) Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. J Surg Res 84:88-93
|
